Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Biologics Show Promise for Bowels
Biologic treatments for inflammatory bowel diseases may help heal the intestines, a new study found.
FDA Warns About IBS Rx Complication
If you've had your gallbladder removed, the US Food and Drug Administration (FDA) is warning that you shouldn't use a particular irritable bowel syndrome medication.
Why the Hepatitis C 'Cure' Rate Spiked
Hepatitis C "cure" rates increased 21-fold between 2010 and 2015, a new study found. That increase is likely due to a transformation in the available treatments.
Hep C, Baby Boomers and Testing
In 2015, nearly 86 percent of baby boomers had never been screened for the hepatitis C virus (HCV), a new study found. And that may put them at unnecessary risk for liver disease.
A New Treatment for Chronic Constipation
The US Food and Drug Administration has approved a new treatment option for chronic constipation.
Too Much Red Meat Might Hurt Your Bowels
Eating a lot of red meat might raise your risk for a common bowel condition called diverticulitis, according to a new study.
A New Player in C. Diff Treatment
The US Food and Drug Administration has approved a new medication to prevent repeat Clostridium difficile infections.
How Your Dentist May Prevent Pneumonia
Seeing your dentist on a regular basis may lower your risk of having bacterial pneumonia, according to an unpublished study presented at a conference.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.